"AMBS" - The one micro-cap biotech to buy now for 2014.
Read the recent Yahoo news and you'll understand why it's a buy here.
Follow the company on Twitter: @AmarantusBio
There is still time to sell your shares for less than a nickle before the share price triples.
Sell today and avoid substantial capital gain taxes.
Someone will buy your shares. Guaranteed.
p.s. You know you don't want to pay more taxes.
Dr. Joseph Rubinfeld, one of Amgen's co-founders, is on AMBS's advisory board.
Becton Dickinson and Novartis are potential partners along with Amgen.
Why does everyone think a reverse split to uplist is a bad thing? Trading on the NASDAQ would open up the stock to be bought by many more investment entities.